LENZ THERAPEUTICS, INC. (LENZ) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$34.06M*; Operating income -$34.17M; Depreciation and amortization $110.00K*.
- 2026-03-31: Basis Reported; EBITDA -$44.02M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$38.36M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$18.76M*; Operating income -$18.89M; Depreciation and amortization $125.00K*.
Complete source-backed ebitda history.
- Available history
- 2023-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$34.06M* | -$34.17M | $110.00K* | $5.49M | -620.89%* | $16.00K* | -$38.71M* | $280.00K | $0.00 | $39.38M | $3.00K |
|---|
| 2026-03-31 | Reported | -$44.02M | (m) | (m) | (m) | -2315.83% | $18.00K | -$33.58M | $1.08M | $0.00 | $44.96M | (m) |
|---|
| 2025-12-31 | Reported | -$38.36M | (m) | (m) | (m) | -2415.37% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$18.76M* | -$18.89M | $125.00K* | (m) | (m) | $439.00K* | -$8.59M* | (m) | $3.79M | $27.60M | $0.00 |
|---|
| 2025-06-30 | Reported | -$16.84M* | -$16.86M | $19.00K* | $5.00M | -336.76%* | $240.00K* | -$11.51M* | $0.00 | $9.06M | $12.80M | $500.00K |
|---|
| 2025-03-31 | Reported | -$16.9M | (m) | (m) | (m) | (m) | $110.00K | -$16.05M | $0.00 | $5.82M | $11.11M | (m) |
|---|
| 2024-12-31 | Reported | -$15.2M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$12.94M* | -$12.95M | $10.00K* | (m) | (m) | $186.00K* | -$10.58M* | (m) | $6.45M | $6.49M | $0.00 |
|---|
| 2024-06-30 | Reported | -$14.33M* | -$14.35M | $18.00K* | (m) | (m) | $133.00K* | -$15.79M* | (m) | $6.95M | $7.41M | $0.00 |
|---|
| 2024-03-31 | Reported | -$16.08M | (m) | (m) | (m) | (m) | $0.00 | -$23.94M | (m) | $10.54M | $5.55M | (m) |
|---|
| 2023-12-31 | Reported | -$24.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$19.86M* | -$19.86M | $4.00K* | (m) | (m) | $0.00* | -$13.09M* | (m) | $17.00M | $2.86M | (m) |
|---|
| 2023-06-30 | Reported | -$14.96M* | -$14.96M | $4.00K* | (m) | (m) | $24.00K* | -$13.52M* | (m) | $12.64M | $2.32M | (m) |
|---|
| 2023-03-31 | Reported | -$12.61M | (m) | (m) | (m) | (m) | $6.00K | -$12.80M | (m) | $10.32M | $2.29M | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$26.15M | (m) | (m) | (m) | $915.00K* | -$22.22M* | (m) | $18.30M | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$26.78M | (m) | (m) | (m) | $1.39M* | -$22.09M* | (m) | $17.78M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$25.96M | (m) | (m) | (m) | $3.27M | -$21.24M | (m) | $18.25M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$14.60M | (m) | (m) | (m) | $3.64M* | -$15.41M* | (m) | $8.68M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$17.53M | (m) | (m) | (m) | $763.00K* | -$13.78M* | (m) | $12.67M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$9.37M | (m) | (m) | (m) | $360.00K | -$8.06M | (m) | $5.38M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$3.76M | (m) | (m) | (m) | $554.00K* | -$2.49M* | (m) | $2.31M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$1.29M | (m) | (m) | (m) | (m) | (m) | (m) | $423.00K | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$90.85M | (m) | (m) | (m) | -475.96% | $827.00K | -$69.17M | $418.00K | $18.67M | $91.14M | $502.00K |
|---|
| 2024-12-31 | Reported | -$58.55M | (m) | (m) | (m) | (m) | $468.00K | -$59.39M | $0.00 | $29.80M | $28.81M | $1.00K |
|---|
| 2023-12-31 | Reported | -$72.41M | (m) | (m) | (m) | (m) | $30.00K | -$60.38M | (m) | $59.50M | $12.93M | -$179.00K |
|---|
| 2022-12-31 | Reported | (m) | -$105.64M | (m) | (m) | (m) | $6.59M | -$87.98M | (m) | $72.79M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | (m) | -$60.44M | (m) | (m) | (m) | $5.74M | -$52.85M | (m) | $37.93M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | (m) | -$13.50M | (m) | (m) | (m) | $1.54M | -$8.72M | (m) | $9.12M | (m) | $0.00 |
|---|